Comparison of Carboplatin With Cisplatin in Small Cell Lung Cancer in US Veterans
Sign Up to like & getrecommendations! Published in 2022 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2022.37699
Abstract: Key Points Question What is the platinum agent of choice in treating small cell lung cancer (SCLC), cisplatin or carboplatin? Findings In this cohort study of 4408 patients at US Veteran Affairs hospitals, there was… read more here.
Keywords: lung cancer; carboplatin; small cell; carboplatin cisplatin ... See more keywords
First‐line pemetrexed/carboplatin or cisplatin/bevacizumab compared with paclitaxel/carboplatin/bevacizumab in patients with advanced non‐squamous non‐small cell lung cancer with wild‐type driver genes: A real‐world study in China
Sign Up to like & getrecommendations! Published in 2019 at "Thoracic Cancer"
DOI: 10.1111/1759-7714.13025
Abstract: The study was conducted to compare the effectiveness and safety of pemetrexed/carboplatin or cisplatin/bevacizumab (PemPBev) and paclitaxel/carboplatin/bevacizumab (PacCBev) as first‐line therapy for advanced non‐squamous non‐small cell lung cancer (NS‐NSCLC) patients with wild‐type driver genes in… read more here.
Keywords: bevacizumab; pemetrexed carboplatin; cisplatin bevacizumab; carboplatin ... See more keywords